Back to 
Farallon Capital Management, L.L.C.
Farallon Capital Management, L.L.C.
VYGR
Showing 5 of 15 quarters
Position history for Farallon Capital Management, L.L.C.'s holdings in Voyager Therapeutics, Inc.
No. Farallon Capital Management exited its VYGR (Voyager Therapeutics) position in Q3 2025. Its Q2 2025 13F listed 715,000 shares worth $2.2M. Farallon Capital Management already held VYGR in its Q4 2018 13F, the earliest on record, and held it in 13 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$13.4M
Total Shares Change
-2.3M
Quarter-by-Quarter History